产地 | 进口、国产 |
品牌 | 上海莼试 |
保存条件 | Store at -20 °C |
货号 | CS11453 |
应用范围 | WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
CAS编号 | |
抗体名 | Anti-Thrombin Activation peptide fragment 2 |
克隆性 | |
靶点 | 详见说明书 |
适应物种 | 详见说明书 |
形态 | 详见说明书 |
宿主 | 详见说明书 |
亚型 | IgG |
标识物 | 详见说明书 |
浓度 | 1mg/1ml% |
免疫原 | KLH conjugated synthetica peptide derived from human Thrombin Activation peptide fragment 2 |
中文名称 凝血酶(凝血因子II)激活肽2抗体费用
英文名称 Anti-Thrombin Activation peptide fragment 2
别 名 Activation peptide fragment 2; coagulation factor II; prothrombin; F2; Cf-2; Cf2; FII; F 2; coagulation factor II (thrombin); Coagulation factor II; Coagulation factor II precursor; F2; Factor II; Factor-II; Prothrombin; prothrombin B-chain; PT; serine protease; THRB; THRB_HUMAN; Thrombin.
产品属性:
凝血酶(凝血因子II)激活肽2抗体费用 浓 度 1mg/1ml
规 格 0.1ml/100μg 0.2ml/200μg
抗体来源 Rabbit
克隆类型 polyclonal
交叉反应 Human, Mouse, Rat, Guinea Pig
产品类型 一抗
研究领域 心 细胞生物 激酶和磷酸酶 合成与降解
蛋白分子量 predicted molecular weight: 14/64kDa
性 状 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from human Thrombin Activation peptide fragment 2
亚 型 IgG
纯化方法 affinity purified by Protein A
储 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
凝血酶(凝血因子II)激活肽2抗体费用 产品应用 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
(石蜡切片需做抗原修复)
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Thrombin is the final protease in the blood coagulation cascade and serves both pro- and anticoagulant functions through the cleavage of several targets. The ability of thrombin to specifically recognize a wide range of substrates derives from interactions which occur outside of the active site of thrombin. Thrombin possesses two anion binding exosites which mediate many of its interactions with cofactors and substrates, and although many structures of thrombin have been solved, few such interactions have been described in molecular detail. Glycosaminoglycan binding to exosite II of thrombin plays a major role in switching off the procoagulant functions of thrombin by mediating its irreversible inhibition by circulating serpins and by its binding to the endothelial cell surface receptor thrombomodulin.
Function : Thrombin is an active enzyme in the earliest steps of the blood clot formation, generated from its circulating inactive precursor prothrombin. Thrombin is a glycoprotein formed by two peptides chains of 36 and 259 amino acids linked by disulfure bonds. Three important sites have been identified on the surface of the enzyme: The catalytic site that confers to the molecule its serine protease activity, the exosite one responsible for the binding of the substrate (fibrinogen or thrombin receptor) and the exosite two responsible for the binding of antithrombin III and inactivation of thrombin. Gamma Thrombin is a proteolyzed form of Alpha Thrombin. Gamma Thrombin consists of four chains (A, B1, B5, B4) with a disulfide link between the A peptide and the B5 peptide.
Subunit : Heterodimer (named alpha-thrombin) of a light and a heavy chain; disulfide-linked. Forms a heterodimer with SERPINA5.
Subcellular Location : Secreted, extracellular space.
Tissue Specificity : Expressed by the liver and secreted in plasma.
Post-translational modifications : The gamma-carboxyglutamyl residues, which bind calcium ions, result from the carboxylation of glutamyl residues by a microsomal enzyme, the vitamin K-dependent carboxylase. The modified residues are necessary for the calcium-dependent interaction with a negatively charged phospholipid surface, which is essential for the conversion of prothrombin to thrombin.
N-glycosylated. N-glycan heterogeneity at Asn-121: Hex3HexNAc3 (minor), Hex4HexNAc3 (minor) and Hex5HexNAc4 (major). At Asn-143: Hex4HexNAc3 (minor) and Hex5HexNAc4 (major).
DISEASE : Factor II deficiency (FA2D) [MIM:613679]: A very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels. Note=The disease is caused by mutations affecting the gene represented in this entry.
Ischemic stroke (ISCHSTR) [MIM:601367]: A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
Thrombophilia due to thrombin defect (THPH1) [MIM:188050]: A multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation. Note=The disease is caused by mutations affecting the gene represented in this entry. A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis.
Pregnancy loss, recurrent, 2 (RPRGL2) [MIM:614390]: A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.
Similarity : Belongs to the peptidase S1 family.
Contains 1 Gla (gamma-carboxy-glutamate) domain.
Contains 2 kringle domains.
Contains 1 peptidase S1 domain.
Database links : UniProtKB/Swiss-Prot: P00734.2
实验流程:
全、新、优、品、好四大特点:
凝血酶(凝血因子II)激活肽2抗体费用 全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材,抗体、培养基、ATCC细胞等,基本上各种科研所需产品在我司都能找到。
新:产品更新速度较快,基本上每周都有新产品出现。
优:产品质量好,投诉比较少。
好:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。
技术外包服务:
★凝血酶(凝血因子II)激活肽2抗体费用 分子生物学:质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学:基因合成、引物合成、基因测序、载体构建等
★蛋白工程:原核、哺乳动物蛋白表达系统等
★病毒包装:腺病毒、慢病毒等
★抗体工程:磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★细胞工程:细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。
正在热销的相关产品:
Anti-TNF- Alpha /HRP 辣根过氧化物酶标记鼠抗人坏死因子-α单克隆抗体IgGMulti-class antibodies规格: 0.2ml
PLGF (Placenta growth factor) 胎盘生长因子(多肽抗原)Multi-class antibodies规格: 0.5mg
腱糖蛋白-C抗体 anti-Tn-C 0.2ml
5HT1E Receptor 英文名称: 5-羟色胺受体1E抗体 0.2ml
EMR1 英文名称: 表皮生长因子样激素受体1 0.2ml
Rhesus antibody Rh Phospho-JunB (Thr102/Thr104) 磷酸化活化蛋白激酶B抗体 规格 0.2ml
PLGF (Placenta growth factor) 胎盘生长因子(多肽抗原)Multi-class antibodies规格: 0.5mg
Anti-TIMP-4/FITC 荧光素标记金属蛋白酶组织抑制因子-4抗体IgGMulti-class antibodies规格: 0.2ml
NOS-2 (iNOS) Nitric Oxide Synthase,Inducible 合成酶-2(抗原)Multi-class antibodies规格: 0.5mg
三碘甲狀腺素T3抗体 Anti-T3 0.2ml
SSX8 英文名称: 滑膜X断点蛋白8抗体 0.1ml
Phospho-Estrogen Receptor alpha (Ser118) 英文名称: 磷酸化雌激素受体α抗体 0.1ml
Rhesus antibody Rh phospho-LRP5(Thr1492) 磷酸化受体相关蛋白5抗体 规格 0.1ml
NOS-2 (iNOS) Nitric Oxide Synthase,Inducible 合成酶-2(抗原)Multi-class antibodies规格: 0.5mg
CD63/MLA1 溶酶体膜糖蛋白抗原Multi-class antibodies规格: 0.5mg
Anti-Bag1/RAP46 抑凋亡基因bag1抗体Multi-class antibodies规格: 0.1ml
Rhesus antibody Rh Phospho-A Raf(Ser299) 磷酸化A-Raf抗体 规格 0.1ml
Ki67 浓缩液 0.1ml 进口分装
UBE2J2 英文名称: 泛素蛋白连接酶J2抗体 0.2ml
CHST12 英文名称: 碳水化合物磺基转移酶12抗体 0.1ml
Anti-Bag1/RAP46 抑凋亡基因bag1抗体Multi-class antibodies规格: 0.1ml
IL7 Protein Human 重组人 IL7 / ierleukin 7 蛋白
胰蛋白酶(含100mL 酶解缓冲液) 10mL
HA Others H4N8 甲型 H4N8 (A/chicken/Alabama/1/1975) 血凝素HA1 (Hemagglutinin) 人细胞裂解液 (阳性对照)
FaDu人咽鳞癌细胞 FaDu human pharyngeal squamous cell carcinoma MEM(GIBCO)+10%FBS
CM-H027人淋巴成纤维细胞完全培养基100mL
人人(HEK-a) ( 5×105 ) 小鼠成纤维细胞(EGFP标记) Mouse
CM-H089人髂动脉内皮细胞完全培养基100mL
IFNA13 Others Cynomolgus 食蟹猴 IFNA13 / Ierferon alpha-13 人细胞裂解液 (阳性对照)
人肠微内皮细胞HIMEC
HS68细胞,人男性正常细胞系 大鼠嗜碱性粒细胞性细胞,RBL-1细胞 平滑肌细胞培养基SMCM
MC3T3-E1 Subclone 14(小鼠颅顶前骨细胞亚克隆14) 5×106cells/瓶×2
AGS(人胃腺癌细胞) 5×106cells/瓶×2 CM-R051大鼠子宫颈上皮细胞完全培养基100mL 人上皮样细胞;BEAS-2B
凝血酶(凝血因子II)激活肽2抗体费用 IL7 Protein Human 重组人 IL7 / ierleukin 7 蛋白
胰蛋白酶(含100mL 酶解缓冲液) 10mL
HA Others H4N8 甲型 H4N8 (A/chicken/Alabama/1/1975) 血凝素HA1 (Hemagglutinin) 人细胞裂解液 (阳性对照)
FaDu人咽鳞癌细胞 FaDu human pharyngeal squamous cell carcinoma MEM(GIBCO)+10%FBS
CM-H027人淋巴成纤维细胞完全培养基100mL
人人(HEK-a) ( 5×105 ) 小鼠成纤维细胞(EGFP标记) Mouse